Drawing for GOTOKNOW

USPTO serial 97528730

GOTOKNOW

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
GILLANI, MAHREEN A
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with GOTOKNOW?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Joshua S. Jarvis, Esq.

Joshua S. Jarvis, Esq. FOLEY HOAG LLP155 SEAPORT BOULEVARDBOSTON, MA 02210United States

Goods and services

ClassDescriptionStatusFirst use
001Testing kits for collecting biological samples composed primarily of reagents and also including one or more of lancets, swabs for medical use, needles for medical purposes, collection tubes, dermal patches, and sample collection cards, all for collecting biological samples for laboratory useACTIVE—
005Genetic test kit comprised primarily of biological sample collection tools, namely, swabs for medical use and also including sample collection cards for collecting biological samples, collection tubes, lancets, and needles for medical purposes, and dermal patches for collecting biological samples for medical purposes, all for collecting biological samples for use in performing genetic tests for medical diagnostic purposes; test kit for home use comprised primarily of biological sample collection tools, namely, swabs for medical use and also including lancets, needles for medical purposes, collection tubes, dermal patches for collecting biological samples for medical purposes and sample collection cards, all for collecting biological samples for medical diagnostic testing; genetic test kits comprised primarily of biological sample collection tools, namely, swabs for medical use and also including dermal patches for collecting biological samples for medical purposes, sample collection cards for collecting biological samples, lancets, needles for medical use, and biological sample collection tubes, all for collecting biological samples for use in performing medical genetic tests; vitamins; dietary supplements; nutritional supplementsACTIVE—
009Genetic test kit comprised primarily of biological sample collection tools, namely, scientific research specimen collection devices in the nature of laboratory swabs, and also including devices in the nature of lancets, needles for medical use, collection tubes, dermal patches for collecting biological samples for medical purposes, and sample collection cards for collecting biological samples, all for laboratory use in performing non-medical genetic tests; test kits comprised primarily of biological sample collection tools, namely, laboratory swabs, scientific research specimen collection devices in the nature of collection tubes and sample collection cards, and also including dermal patches for collecting biological samples for medical purposes and needles for medical use, all for collecting biological samples for laboratory use in performing genetic tests for nonmedical purposes; test kits comprised primarily of laboratory swabs, and also including lancets, needles for medical use, collection tubes, dermal patches for collecting biological samples for medical purposes, and sample collection cards, all for collecting biological samples, for laboratory use; downloadable mobile application software for reviewing, sharing, and analyzing results of non-medical, medical, genetic, and diagnostic tests; downloadable mobile application software featuring instructions and instructional videos related to medical, genetic, and diagnostic tests; downloadable mobile application software featuring in-app purchases of digital and physical goods related to or derived from medical, genetic, and diagnostic tests and test results; downloadable mobile application software featuring in-app purchases of vitamins, dietary supplements, and nutritional supplements; downloadable reports for reporting the results of non-medical, medical, genetic and diagnostic tests; downloadable reports for reporting the results of non-medical, medical, genetic and diagnostic tests for medical, non-medical, genetic, health, wellness and fitness conditions; downloadable reports providing analyses and recommendations related to genetic testing and test resultsACTIVE—
010Test kits comprised of medical instruments, namely, sample preparation devices for medical diagnostic use, medical diagnostic instruments for the analysis of body fluids, lancets, needles for medical use, sample collection cards, dermal patches for collecting biological samples for medical purposes, and collection tubes, and also including medical swabs for taking biological samples for review and testing for various medical and genetic conditions; medical diagnostic testing kits consisting primarily of collection tools, namely, dermal patches for collecting biological samples for medical purposes, lancets, needles, collection tubes, and sample collection cards, and also including medical swabs, instructions and return shipping packaging, all for the collection of biological samples for use in testing, diagnosing and monitoring various medical and genetic conditions and diseasesACTIVE—
035Online retail store services featuring medical, genetic and diagnostic tests and testing kits for collecting biological samples for personal, laboratory, scientific, and industrial use; online retail store services featuring cosmetics, foods, medical devices, and nutritional and weight loss products related to or derived from medical, genetic, and diagnostic tests and test results; online retail store services featuring digital goods in the nature of downloadable digital reports for reporting the results of nonmedical, medical, genetic and diagnostic tests, downloadable digital reports providing analyses and recommendations related to genetic testing and test results, all related to or derived from medical, genetic, and diagnostic tests and test results; online retail store services featuring vitamins, dietary supplements, and nutritional supplementsACTIVE—
042Providing scientific analysis and scientific information regarding the results of laboratory and non-laboratory testing in the field of various non-medical, medical, genetic, health, wellness, and fitness related diseases and conditions; providing scientific analysis and scientific information regarding the results of testing in the field of various non-medical, medical, genetic, health, wellness, and fitness related diseases and conditions; providing medical research information regarding results of testing for various medical and genetic conditions and diseases; genetic testing of biological samples for scientific and medical research; providing temporary use of non-downloadable software for reporting the results of genetic tests and non-medical, medical and genetic diseases and conditions; providing non-medical research and scientific information in the fields of medicine, health, wellness and fitness; providing genetic testing for scientific research purposes in the fields of medicine, health, wellness and fitness for research purposes; software as a service (SAAS) services featuring software for reviewing, sharing, and analyzing results of medical, genetic, and diagnostic tests; software as a service (SAAS) services featuring software featuring instructions and instructional videos related to medical, genetic, and diagnostic tests; software as a service (SAAS) services featuring software that allows users to purchase digital and physical goods related to or derived from medical, genetic, and diagnostic tests and test results; software as a service (SAAS) services featuring software that allows users to purchase vitamins, dietary supplements, and nutritional supplementsACTIVE—
044Medical, genetic and diagnostic testing and reporting services for medical purposes; medical testing services relating to the diagnosis and treatment of disease; medical, genetic and diagnostic testing of biological samples for treatment, identification, or monitoring of various medical and genetic diseases and conditions for medical purposes; medical, genetic and diagnostic testing of biological samples for treatment, identification, or monitoring of various medical and genetic diseases and conditions, namely, collecting and testing biological samples for medical purposes, providing laboratory and non-laboratory medical and genetic testing for medical purposes, and medical and genetic information services, namely, reporting test results to customers, healthcare providers and patients for medical purposes; genetic testing of biological samples for medical purposes; medical testing of biological samples for diagnostic, informational, or monitoring purposes to provide users with personalized information for maintaining health and wellness; genetic testing of biological samples for medical diagnostic and treatment purposes; genetic testing of biological samples, namely, using biological samples for medical diagnostic and treatment purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Feb 2, 2026MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Feb 2, 2026ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Sep 15, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 4, 2025EX1GSOU EXTENSION 1 GRANTED—
Jun 4, 2025EXT1SOU EXTENSION 1 FILED—
Jun 4, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 31, 2024NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Nov 19, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 19, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 13, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 7, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 7, 2024XAECEXAMINER'S AMENDMENT ENTERED—
Oct 7, 2024GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Oct 7, 2024GNEAEXAMINERS AMENDMENT E-MAILED—
Oct 7, 2024CNEAEXAMINERS AMENDMENT -WRITTEN—
Oct 3, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 3, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 3, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 25, 2024XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Jul 25, 2024XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
May 8, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 8, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 8, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 29, 2024ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Mar 12, 2024PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Feb 28, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 28, 2024XAECEXAMINER'S AMENDMENT ENTERED—
Feb 28, 2024GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Feb 28, 2024GNEAEXAMINERS AMENDMENT E-MAILED—
Feb 28, 2024CNEAEXAMINERS AMENDMENT -WRITTEN—
Feb 28, 2024ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Feb 27, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 27, 2024XAECEXAMINER'S AMENDMENT ENTERED—
Feb 27, 2024GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Feb 27, 2024GNEAEXAMINERS AMENDMENT E-MAILED—
Feb 27, 2024CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 22, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 22, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 22, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 4, 2023GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 4, 2023GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 4, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 11, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 11, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 11, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 13, 2023XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Jul 13, 2023XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Apr 19, 2023GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 19, 2023GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 19, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 21, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 21, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 21, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 31, 2022GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 31, 2022GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 31, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 27, 2022DOCKASSIGNED TO EXAMINER—
Aug 22, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 4, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance